Multiple_Myeloma_Research_Review_Issue_43Download
Research Review
Multiple Myeloma Research Review
Multiple_Myeloma_Research_Review_Issue_42Download
Myeloma Research Review – Issue 39
Welcome to issue 39 of Multiple Myeloma Research Review. This issue’s selection includes research reporting that switching elderly intermediate-fit...
Myeloma Research Review – Issue 37
Welcome to issue 37 of Multiple Myeloma Research Review. This issue begins with a retrospective, multinational report describing the clinical...
Myeloma Research Review – issue 36
Welcome to issue 36 of Multiple Myeloma Research Review. The use of ixazomib-based induction therapy in routine clinical practice is relatively...
Multiple Myeloma Research Review
Highlights include: Associations with OS in NZ MM patients VTE risk with lenalidomide regimens for MM despite thromboprophylaxis Retrospective study...
Multiple Myeloma Research Review
Highlights include: Daratumumab + standard care in newly diagnosed MM OS with daratumumab + bortezomib/melphalan/prednisone in newly diagnosed MM...
Multiple Myeloma Research Review
Highlights include: • Once-weekly vs twice weekly carfilzomib for newly diagnosed MM • Negative trials for pembrolizumab in treatment naive and...
Impact of age, sex, ethnicity, socio-economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New Zealand
The impact of age, ethnicity and socio-economic deprivation in the era of novel anti-myeloma agents is unclear. Using linked national data from New...
Multiple Myeloma Research Review
Highlights include: • Increased novel agent access in NZ improved MM survival • Pomalidomide-based regimens for relapsed/refractory MM •...
Multiple Myeloma Research Review
Highlights include: • Anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma. • MGUS risk in relatives of patients with multiple...
Living well with Myeloma
This guide is written for people who have been diagnosed with myeloma. It will also be helpful for their families, friends and health professionals....